Exemestane Versus Tamoxifen
PSGS_BSG 2013 CPG Early Breast CA Full Text
1 Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive.
Breast Cancer - the Evidence for Current Management
DCIS – Are we cutting it?
June 2009 Vol. 2 No. 4
